The regulatory framework around medicinal cannabis has a long history, beginning with the Single Convention on Narcotic Drugs of 1961.
The Single Convention aims to combat drug abuse by coordinated international action. It seeks to limit the possession, use, trade, distribution, import, export, manufacture and production of drugs exclusively to medical and scientific purposes. It also combats drug trafficking through international cooperation to deter and discourage drug traffickers.
Legislation to enable the cultivation of cannabis for medicinal and related research purposes in Australia was passed by Parliament on 29 February 2016. The amendments relating to licensing came into effect on 30 October 2016. A detailed regulatory framework has been put in place to enable applications for licences and permits for the cultivation, production and manufacture of medicinal cannabis products.
Cultivation of medicinal cannabis plants and subsequent production of medicinal cannabis oils and products is regulated by The Office of Drug Control (ODC) via issuance of a number of licenses.
OneLife Botanicals is an approved licensee and has complied with the ODC requirements that set out the types and amount of cannabis that can be grown and/or produced and the types and quantities of medicinal cannabis products that can be manufactured under the issued licence.